These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 11013215)
1. CD95 (APO-1/Fas) linkage to the actin cytoskeleton through ezrin in human T lymphocytes: a novel regulatory mechanism of the CD95 apoptotic pathway. Parlato S; Giammarioli AM; Logozzi M; Lozupone F; Matarrese P; Luciani F; Falchi M; Malorni W; Fais S EMBO J; 2000 Oct; 19(19):5123-34. PubMed ID: 11013215 [TBL] [Abstract][Full Text] [Related]
2. CD95/phosphorylated ezrin association underlies HIV-1 GP120/IL-2-induced susceptibility to CD95(APO-1/Fas)-mediated apoptosis of human resting CD4(+)T lymphocytes. Luciani F; Matarrese P; Giammarioli AM; Lugini L; Lozupone F; Federici C; Iessi E; Malorni W; Fais S Cell Death Differ; 2004 May; 11(5):574-82. PubMed ID: 14739941 [TBL] [Abstract][Full Text] [Related]
3. The role of FAS to ezrin association in FAS-mediated apoptosis. Fais S; De Milito A; Lozupone F Apoptosis; 2005 Oct; 10(5):941-7. PubMed ID: 16151629 [TBL] [Abstract][Full Text] [Related]
4. Cisplatin-induced apoptosis involves a Fas-ROCK-ezrin-dependent actin remodelling in human colon cancer cells. Rebillard A; Jouan-Lanhouet S; Jouan E; Legembre P; Pizon M; Sergent O; Gilot D; Tekpli X; Lagadic-Gossmann D; Dimanche-Boitrel MT Eur J Cancer; 2010 May; 46(8):1445-55. PubMed ID: 20202822 [TBL] [Abstract][Full Text] [Related]
5. Roles of p-ERM and Rho-ROCK signaling in lymphocyte polarity and uropod formation. Lee JH; Katakai T; Hara T; Gonda H; Sugai M; Shimizu A J Cell Biol; 2004 Oct; 167(2):327-37. PubMed ID: 15504914 [TBL] [Abstract][Full Text] [Related]
6. P-glycoprotein-actin association through ERM family proteins: a role in P-glycoprotein function in human cells of lymphoid origin. Luciani F; Molinari A; Lozupone F; Calcabrini A; Lugini L; Stringaro A; Puddu P; Arancia G; Cianfriglia M; Fais S Blood; 2002 Jan; 99(2):641-8. PubMed ID: 11781249 [TBL] [Abstract][Full Text] [Related]
7. Identification and relevance of the CD95-binding domain in the N-terminal region of ezrin. Lozupone F; Lugini L; Matarrese P; Luciani F; Federici C; Iessi E; Margutti P; Stassi G; Malorni W; Fais S J Biol Chem; 2004 Mar; 279(10):9199-207. PubMed ID: 14676203 [TBL] [Abstract][Full Text] [Related]
8. Ezrin, actin and cytoskeleton in apoptosis of esophageal epithelial cells induced by arsenic trioxide. Shen ZY; Xu LY; Li EM; Li JT; Chen MH; Shen J; Zeng Y Int J Mol Med; 2003 Sep; 12(3):341-7. PubMed ID: 12883650 [TBL] [Abstract][Full Text] [Related]
9. MAPK/ERK signaling in activated T cells inhibits CD95/Fas-mediated apoptosis downstream of DISC assembly. Holmström TH; Schmitz I; Söderström TS; Poukkula M; Johnson VL; Chow SC; Krammer PH; Eriksson JE EMBO J; 2000 Oct; 19(20):5418-28. PubMed ID: 11032809 [TBL] [Abstract][Full Text] [Related]
10. Viral regulation of CD95 expression and apoptosis in T lymphocytes. Sieg S; Huang Y; Kaplan D J Immunol; 1997 Aug; 159(3):1192-9. PubMed ID: 9233613 [TBL] [Abstract][Full Text] [Related]
11. CD95 capping is ROCK-dependent and dispensable for apoptosis. Söderström TS; Nyberg SD; Eriksson JE J Cell Sci; 2005 May; 118(Pt 10):2211-23. PubMed ID: 15855233 [TBL] [Abstract][Full Text] [Related]
12. Identification of a lysine-rich region of Fas as a raft nanodomain targeting signal necessary for Fas-mediated cell death. Rossin A; Kral R; Lounnas N; Chakrabandhu K; Mailfert S; Marguet D; Hueber AO Exp Cell Res; 2010 May; 316(9):1513-22. PubMed ID: 20298688 [TBL] [Abstract][Full Text] [Related]
13. CD95-mediated apoptosis is impaired at receptor level by cellular FLICE-inhibitory protein (long form) in wild-type p53 human ovarian carcinoma. Mezzanzanica D; Balladore E; Turatti F; Luison E; Alberti P; Bagnoli M; Figini M; Mazzoni A; Raspagliesi F; Oggionni M; Pilotti S; Canevari S Clin Cancer Res; 2004 Aug; 10(15):5202-14. PubMed ID: 15297424 [TBL] [Abstract][Full Text] [Related]
14. Relationship between proliferation and susceptibility to CD95- and CD2-mediated apoptosis in stimulated primary T lymphocytes: T cells manifesting proliferative unresponsiveness are preferentially susceptible to CD95-mediated apoptosis. Mollereau B; Blanchard D; Déas O; Dumont C; Métivier D; Bernard A; McGrew JT; Charpentier B; Vazquez A; Senik A J Immunol; 1997 Sep; 159(6):2668-77. PubMed ID: 9300686 [TBL] [Abstract][Full Text] [Related]
15. Metabolic inhibitors sensitize for CD95 (APO-1/Fas)-induced apoptosis by down-regulating Fas-associated death domain-like interleukin 1-converting enzyme inhibitory protein expression. Fulda S; Meyer E; Debatin KM Cancer Res; 2000 Jul; 60(14):3947-56. PubMed ID: 10919673 [TBL] [Abstract][Full Text] [Related]
16. Triggering of transient receptor potential vanilloid type 1 (TRPV1) by capsaicin induces Fas/CD95-mediated apoptosis of urothelial cancer cells in an ATM-dependent manner. Amantini C; Ballarini P; Caprodossi S; Nabissi M; Morelli MB; Lucciarini R; Cardarelli MA; Mammana G; Santoni G Carcinogenesis; 2009 Aug; 30(8):1320-9. PubMed ID: 19502594 [TBL] [Abstract][Full Text] [Related]
17. Cellular distributions of the ERM proteins in MDCK epithelial cells: regulation by growth and cytoskeletal integrity. Woodward AM; Crouch DH Cell Biol Int; 2001; 25(3):205-13. PubMed ID: 11352493 [TBL] [Abstract][Full Text] [Related]
18. Molecular mechanisms of APO-1/Fas(CD95)-mediated apoptosis in tolerance and AIDS. Dhein J; Walczak H; Westendorp MO; Bäumler C; Stricker K; Frank R; Debatin KM; Krammer PH Behring Inst Mitt; 1995 Jun; (96):13-20. PubMed ID: 7575348 [TBL] [Abstract][Full Text] [Related]
19. Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells. Induction and modulation of sensitivity by cytokines. Weller M; Frei K; Groscurth P; Krammer PH; Yonekawa Y; Fontana A J Clin Invest; 1994 Sep; 94(3):954-64. PubMed ID: 7521890 [TBL] [Abstract][Full Text] [Related]
20. Resistance to CD95 (APO-1/Fas)-mediated apoptosis in human renal cell carcinomas: an important factor for evasion from negative growth control. Gerharz CD; Ramp U; Déjosez M; Mahotka C; Czarnotta B; Bretschneider U; Lorenz I; Müller M; Krammer PH; Gabbert HE Lab Invest; 1999 Dec; 79(12):1521-34. PubMed ID: 10616203 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]